The OMNI ADRD External Advisory Board (EAB) convenes various experts in aging and cognition to guide the direction and progress of the overall OMNI ADRD project, which aims to develop a repository of free, high-quality research tools for the early detection and prevention of AD and related dementias. Throughout the year, EAB members help establish research priorities, suggest coordinated activities, and review and monitor progress of the OMNI ADRD initiative.

Deanna Barch, PhD

Deanna Barch, PhD
Gregory Jicha, MD, PhD

Gregory Jicha, MD, PhD
Maria Carrillo, PhD

Maria Carrillo, PhD
María Marquine, PhD

María Marquine, PhD
Sarah Walter, MSc

Sarah Walter, MSc
Satrajit Ghosh, PhD

Satrajit Ghosh, PhD
Deanna Barch, PhD

Deanna Barch, PhD

Deanna Barch, Ph.D., is the Vice Dean of Research in Arts & Sciences at Washington University.  She is also the Couch Professor of Psychiatry and a Professor of Radiology, and the Deputy Editor at Biological Psychiatry and Editor-in-Chief of Biological Psychiatry: Global Open Science. Dr. Barch is on the scientific boards of the Brain and Behavior Research Foundation, the One Mind Foundation, the Stanley Foundation, and the Bipolar Discovery Initiative. She served on the Executive Committee of the Association for Psychological Science and the Scientific Council of the National Institute of Mental Health and is currently President of the FLUX Cognitive Neuroscience Society and President of the American College of Neuropsychopharmacology. Her research focuses on understanding normative patterns of cognitive function and brain connectivity, and on the mechanisms that give rise to the behavioral and cognitive challenges found in illnesses such as schizophrenia and depression, using psychological, neuroimaging, and computational approaches across the lifespan. Dr. Barch is a Fellow of the Association for Psychological Science, the American College of Neuropsychopharmacology, and the American Association for the Advancement of Science, and a member of the Society for Experimental Psychology.  She is also a member of the National Academy of Medicine (NAM) and the American Academy of Arts & Sciences, and Co-Chair of the NAM Neuroscience Forum.

Gregory Jicha, MD, PhD

Gregory Jicha, MD, PhD

Gregory Jicha, M.D., Ph.D., is a Professor and Vice Chair for Academic Affairs in the Department of Neurology and Associate Director for the Sanders-Brown Center on Aging and the Robert T. & Nyles Y. McCowan Endowed Chair in Alzheimer’s Research at the University of Kentucky (UK). Dr. Jicha serves as the Director of the Clinical Core of the UK Alzheimer’s Disease Center, the founder and Director of the Rural Kentucky Telemedicine Cognitive Clinic, the principal investigator of the UK National Alzheimer’s Disease Cooperative Study (ADCS) Group, the Alzheimer’s Clinical Trial Consortium (ACTC), the NIH/NINDS MarkVCID consortium, and has served for over 15 years on the Clinical Task Force and Steering Committee for the NIH/NIA Alzheimer’s Disease Center Program. He has served as Chair of the American Academy of Neurology Geriatric section, and as Chair for the International Alzheimer’s Association Clinical Trials Advancement and Methodology Section. He was a founding member of the International Working Group on AD and the International Society for Frontotemporal Dementia.

Maria Carrillo, PhD

Maria Carrillo, PhD

Maria Carrillo, Ph.D., is the Chief Science Officer and Medical Affairs Lead for the Alzheimer’s Association. Dr. Carrillo oversees the implementation of the Association’s growing portfolio of research initiatives, including the Alzheimer’s Association International Conference® (AAIC®), the world’s largest and most influential dementia science meeting. She is a co-principal investigator for the Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET), which is designed to track the long-term clinical response and safety outcomes of enrolled patients being treated with novel FDA-approved Alzheimer’s therapies. In addition, she leads the Association’s direct involvement in research by serving as a co-primary investigator for the Association-funded and led U.S. POINTER study, a lifestyle intervention trial to prevent cognitive decline and dementia. Under her leadership, the Association is the world’s largest nonprofit funder of Alzheimer’s research — currently investing more than $450 million — and an internationally recognized pioneer in convening the dementia science community. Dr. Carrillo uses her platform as a noted public speaker to play an instrumental role in the Association’s efforts to lobby for increased funding for the disease.

María Marquine, PhD

María Marquine, PhD

María Marquine, Ph.D., is an Associate Professor in the Department of Medicine (Division of Geriatrics) and the Department of Psychiatry and Behavioral Sciences at the Duke University School of Medicine, and Associate Scientific Director for Research Career Development at the Duke Center for the Study of Aging and Human Development. She is a clinical scientist with expertise in cross-cultural neuropsychology and aging. Her program of research centers on addressing AD/ADRD disparities, with a focus on the development of tools for the accurate identification of neurocognitive disorders among Hispanic/Latino people living in the United States. She is committed to supporting the development of early career scientists and serves in leadership roles in various NIH-funded research training programs, including being Director of the T32 Duke Aging Center Postdoctoral Research Training Program and Co-Lead of the Research Education Component of the Duke/University of North Carolina Alzheimer’s Disease Research Center.

Sarah Walter, MSc

Sarah Walter, MSc

Sarah Walter, M.Sc., leads the Public and Participant Involvement for Clinical trials at the Alzheimer’s Therapeutic Research Institute (ATRI) at the University of Southern California. Her role is to build the capacity of community members as active and equitable partners in research.  She founded the ACTC Research Participant Advisory Board, and the ACTC-Down Syndrome and Alzheimer’s Biomarkers Consortium Down Syndrome Research Partnership Group. Both groups involve research participants and community members in providing feedback on clinical trial study design, participant-facing communication, and facilitating stronger support for participants and study partners. She is also the Program Administrator for the Alzheimer’s Clinical Trials Consortium, fostering collaboration within the community of Alzheimer’s disease research clinical trial sites and academic and industry study teams.

Satrajit Ghosh, PhD

Satrajit Ghosh, PhD

Satrajit Ghosh, Ph.D., is a Senior Research Scientist at MIT’s McGovern Institute for Brain Research, where he directs the Open Data in Neuroscience Initiative, and an Assistant Professor of Otolaryngology – Head and Neck Surgery at Harvard Medical School. As both a computer scientist and computational neuroscientist, Dr. Ghosh leads the Senseable Intelligence Group, which combines neuroimaging, phenotyping, and machine learning to make brain and mental health research more reliable, equitable, and reproducible. His research spans the neural basis and clinical translation of human communication, AI for precision psychiatry and medicine, and open infrastructure for reproducible research and knowledge generation. He is a PI and MPI on several NIH BRAIN Initiative projects, including the BICAN brain knowledge base, DANDI, the BBQS AI and Data Coordinating Center (BARD.CC), as well as the NIH Bridge2AI Public Precision Health Grand Challenge. Dr. Ghosh is a long-standing advocate for open, collaborative science.